ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 761834 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 761834; 2) Community: the network communities that were significantly associated with the response to NSC 761834; 3) Molecule: the relationships between components within communities and NSC 761834; 4) MDR: the compounds that were significantly associated with the NSC 761834.

NSC Compound Enrichment Correlation
NSC 701023 Aceanthryleno[1,2-b]quinoxaline, 12-nitro- 0.043472147060915 0.23126384
NSC 710326 Null 0.043472147060915 0.23902512
NSC 711077 Null 0.043472147060915 0.18855775
NSC 718630 Null 0.043472147060915 0.34170956
NSC 718781 Erlotinib hydrochloride 0.043472147060915 -0.082334879
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.043472147060915 -0.23515133
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.043472147060915 0.20713786
NSC 725098 Null 0.043472147060915 0.31336918
NSC 726217 Combretastatin A4-analogue 0.043472147060915 0.33863467
NSC 735472 (2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol 0.043472147060915 0.18816051
Total:96  Current:71    [First] [Prev] [Next] [Last]